July 15, 2024:
The Big Ten Cancer Research Consortium has launched new episodes for each of our podcast series: “Bridging the Gap” and “AYA Cancer in Focus.”
- Home
- About Us
- News & Events
- Leadership
- Raymond J. Hohl, MD, PhD
- Raphael E. Pollock, MD, PhD
- Monika Joshi, MD, MRCP
- Oana Danciu, MD
- Timothy Fan, PhD, DVM
- Nabil Adra, MD
- Muhammad Furqan, MD
- Vu Hong Duong, MD, MS
- Aki Morikawa, MD, PhD
- Daniel Isaac, DO
- Veronika Bachanova, MD, PhD
- Vijaya Raj Bhatt, MBBS, MS
- Jyoti Patel, MD
- John L. Hays, MD, PhD
- Patrick C. Ma, MD, MSc
- Thomas G. Sors, PhD
- Salma Jabbour, MD
- Kari Wisinski, MD
- Member Institutions
- University of Illinois Cancer Center
- The Cancer Center at Illinois
- Indiana University Melvin and Bren Simon Comprehensive Cancer Center
- Holden Comprehensive Cancer Center, University of Iowa
- The University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center
- University of Michigan Rogel Cancer Center
- Michigan State University Cancer Research
- Masonic Cancer Center, University of Minnesota
- Fred & Pamela Buffett Cancer Center (University of Nebraska)
- Robert H. Lurie Comprehensive Cancer Center of Northwestern University
- The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute
- Penn State Cancer Institute
- Purdue University Institute for Cancer Research
- Rutgers Cancer Institute of New Jersey
- Fred Hutch Cancer Center
- University of Wisconsin Carbone Cancer Center
- Clinical Research
- Current Trials
- Research Criteria
- Diversity Resources
- Adolescent and Young Adult Clinical Trial Working Group
- Basket Trial Clinical Trial Working Group
- Bone Marrow / Stem Cell Transplant Clinical Trial Working Group
- Breast Cancer Clinical Trial Working Group
- Comparative Oncology Working Group
- Correlative Sciences Clinical Trial Working Group
- Gastrointestinal Clinical Trial Working Group
- Genitourinary Clinical Trial Working Group
- Gynecologic Clinical Trial Working Group
- Head and Neck Clinical Trial Working Group
- Lymphoid Malignancies Clinical Trial Working Group
- Melanoma/Cutaneous Oncology Clinical Trial Working Group
- Multiple Myeloma Clinical Trial Working Group
- Myeloid Malignancies Clinical Trial Working Group
- Neuro-Oncology Clinical Trial Working Group
- Population Science Working Group
- Sarcoma Clinical Trial Working Group
- Thoracic Clinical Trial Working Group
- Donate
- Contact
News & Developments
Dr. Mark Burkard named director of Holden Comprehensive Cancer Center
July 12, 2024: Mark Burkard, MD, PhD, has been named director of Holden Comprehensive Cancer Center at the University of Iowa, and will begin his new role on October 1, pending approval from the Iowa Board of Regents. He will also begin as professor in the Department of Internal Medicine in the Division of Hematology, Oncology, and Blood Marrow Transplantation in the Carver College of Medicine. Read More
BTCRC-GU16-043 published in Nature Communications
May 29, 2024: A Big Ten Cancer Research Consortium (Big Ten CRC) study was published in Nature Communications on February 1, 2024. The article is titled, “Durvalumab and guadecitabine in advanced clear cell renal cell carcinoma: results from the phase Ib/II study BTCRC-GU16-043.” Read More
Dr. Monika Joshi re-appointed as the chief scientific officer of the Big Ten CRC
May 28, 2024: Monika Joshi, MD, MRCP, has been re-appointed as the chief scientific officer of the Big Ten Cancer Research Consortium. Read More
Big Ten CRC’s Presence at ASCO
May 15, 2024: The Big Ten Cancer Research Consortium (Big Ten CRC) is set to participate in the American Society of Clinical Oncology® (ASCO) 2024 Annual Meeting in Chicago from May 31 to June 4. During the event, three Big Ten CRC studies will be presented, working group meetings will take place, and the Big Ten CRC will host a joint reception with Hoosier Cancer Research Network (HCRN). The Big Ten CRC will also be represented in the exhibit hall at HCRN’s booth, #37113. Read More
Hohl appointed chair of Big Ten Cancer Research Consortium Directors Committee
May 9, 2024: Raymond J. Hohl, MD, PhD, was recently named chair of the Cancer Center Directors Committee for the Big Ten Cancer Research Consortium (Big Ten CRC). In this role, Dr. Hohl will help guide strategic priorities for the Big Ten CRC as the consortium enters its second decade. Dr. Hohl has been a member of the leadership committee since the consortium’s founding in 2013 and succeeds Howard Bailey, MD, director of the University of Wisconsin Carbone Cancer Center, as the committee chair. Read More
Danciu appointed chair of steering committee for Big Ten CRC
May 7, 2024: The Big Ten Cancer Research Consortium (Big Ten CRC) recently appointed Oana Danciu, MD, as chair of the consortium’s steering committee. Dr. Danciu is associate director of clinical research at the University of Illinois Cancer Center, a breast oncologist at UI Health, and associate professor in the Division of Hematology and Oncology at the University of Illinois College of Medicine Chicago. She succeeds Vijaya Raj Bhatt, MBBS, MS, of the University of Nebraska Medical Center, as chair of the committee.
Fierce Big Ten Rivals Join Forces Against Cancer
May 3, 2024: The Big Ten Cancer Research Consortium (Big Ten CRC) is excited to announce the release of a new public service announcement (PSA), showcasing the importance of scientific research collaboration among the Big Ten Cancer Centers. This PSA appears on the Big Ten Network. Read More
Adolescent and Young Adult Cancer in Focus: A Big Ten CRC Podcast
April 12, 2024: The Big Ten Cancer Research Consortium (Big Ten CRC) is excited to announce the release of our new podcast, “Adolescent and Young Adult Cancer in Focus.” In this podcast, members of the Big Ten CRC and their colleagues discuss current issues and topics in adolescent and young adult (AYA) cancer research and survivorship. Its purpose is to inform, increase awareness, and educate Big Ten CRC members, families, and patients about AYA oncology. Read More
Summit highlights 10 years of Big Ten CRC collaboration
December 3, 2023: Bringing the best ideas forward, pulling expertise across cancer centers, connecting through mentorships, and ensuring racial, ethnic and gender diversity in clinical trial participation are critical components of the Big Ten Cancer Research Consortium (Big Ten CRC), according to Chief Scientific Officer Monika Joshi, MD, MRCP, from the Penn State Cancer Institute, who spoke at the Big Ten CRC Summit 2023, which brought together more than 110 researchers, investigators, cancer centers, and industry participants. Read More
Illinois
University of Illinois
Indiana
Indiana University
Iowa
University of Iowa
Maryland
University of Maryland
Michigan
University of Michigan
Michigan State
Michigan State
Minnesota
University of Minnesota
Nebraska
University of Nebraska
Northwestern
Northwestern University
Ohio State
Penn State
Penn State University
Purdue
Purdue University
Rutgers
Rutgers State University
Washington
University of Washington
Wisconsin
University of Wisconsin
UIC
University of Illinois at Chicago
Subscribe to the Big Ten CRC Newsletter
X
Facebook
YouTube